BioLife Solutions, Inc.

05/28/2026

🚀 The future of cell and gene therapy manufacturing is taking shape… 🚀

We’re thrilled to announce The Cell Summit ’26 is being held from July 28-29 at the Cincinnati Zoo & Botanical Garden this year in partnership with Cincinnati Children’s Hospital Applied Gene & Cell Therapy Center.

This year’s meeting brings together innovators, scientists, process engineers, and industry leaders to tackle real-world operational challenges shaping advanced therapies today.

From cryopreservation and automation to scale-up strategy and clinical manufacturing realities, this collaborative event is designed to drive actionable solutions across the CGT ecosystem.

NEW this year: Case study working sessions on Day 2. 📑

🗨️ Join the conversation in Cincinnati this July and connect with the experts advancing the next generation of CGTs!

➡️ Learn more & register today: https://biolifesolutions.com/the-cell-summit/

05/21/2026

Time is flying by! ⌛ We won the Biotech Innovation Award at INTERPHEX for our CellSeal® CryoCase rigid container exactly ONE month ago.

It was a proud moment to be recognized for our innovation and engineering work efforts. We’ve specifically designed the CellSeal CryoCase to mitigate common issues with cryobags in the advanced therapy space.

Challenges of cryobags that CryoCase addresses:

🆘 Fragility/Breakage
🆘 Unstackable
🆘 Awkward and time consuming to handle
🆘 Requires multiple operators
🆘 Difficult to inspect due to the translucent material composition
🆘 Contamination/particulates

Thank you to our loyal customers, the INTERPHEX staff & judges, and the BioLife team!

👉 Learn more about CryoCase: https://www.biolifesolutions.com/handling/cellseal-cryocase/

https://youtu.be/K6qVf1XfEjQ?si=h0yeBoT8POjn6oAi

Cell and gene therapies demand precision at every step — including storage and handling.In this video, BioLife Solutions compares traditional cryobags to the...

05/19/2026

It’s that time of year…the 2026 Fred Hutch Obliteride 5K event is on!

Join us on August 8 in Seattle at the University of Washington. Many of our team members will be walking or running this 5K event.

If you haven’t heard, Obliteride is a fundraising event for cancer research, individual scientists, and programs at Fred Hutch Cancer Center. 🔬

If you participate, you can choose an area you would like your funds to go to – such as a specific disease area, program, clinician, or researcher. Learn more: https://www.obliteride.org/about/where-the-money-goes.html

We’re so proud to sponsor this event. If you would like to donate to BioLife’s team, please do so here: https://secure.fredhutch.org/site/TR?team_id=24460&pg=team&fr_id=2251

Thanks for your support. 🧡🙏

https://youtu.be/U5ipnPfiUak?si=2MKMYc6Hy_bxhXDw

Fred Hutch Obliteride launches on April 9, 2026!Fred Hutch Oblite...

05/14/2026

Can your choice of a particular storage container affect cell therapy outcomes? Yes, it can!

In a new interactive infographic with Cell & Gene Therapy Insights, we explore five different ways that container packaging can affect your product quality, regulatory reviews, and commercial readiness.💡

You will discover how packaging:
💥 Influences post-thaw cell viability and the reliability of QC data

💥 Maintains a closed process throughout fill/finish and QC sampling

💥 Enables manufacturability, scalability, and long-term commercial supply

View the infographic here: https://www.insights.bio/cell-and-gene-therapy-insights/journal/article/3797/5-ways-packaging-impacts-cell-therapy-outcomes

05/13/2026

Congratulations to Dr. Jason Acker of PanTHERA CryoSolutions Inc., part of BioLife Solutions, on his acceptance of being a new Scientific Board Member at NSF ERC Advanced Technologies for the Preservation of Biological Systems (NSF ATP-Bio). 👏

ATP-Bio’s goals are to significantly expand the capacity to preserve and transport cells, tissues, organs, etc. through a collaborative effort focused on developing innovative and modern biopreservation technologies.

Dr. Acker is looking forward to applying his expertise in cryopreservation, stem cells, bioinformatics, and hematology to benefit various pioneering studies and programs at ATP-Bio.

Image Credit: ATP-Bio; Convergent research approach at ATP-Bio.

05/12/2026

In a recent episode of the Molecule to Market podcast, host Raman Sehgal spoke with Sean Werner, our Chief Technology Officer, on cell and gene therapy innovations and where the industry is heading. 🎙️

Two highlights include:
❄️ The essential role of cryopreservation, and why it remains a missed risk in R&D for advanced therapies.

⚗️ How the CGT industry is positioned to spread into more specialized areas, creating new therapeutic applications.

Learn more about this episode: https://ow.ly/RPmo50YXOHP

🎧 Ways to Listen:
Apple: https://ow.ly/ws9x50YXOHQ
Spotify: https://ow.ly/IVqy50YXOHO
Amazon: https://ow.ly/3uX050YXOHN

05/07/2026

BioLife Solutions Reports First Quarter 2026 Financial Results

Total revenue of $27.5 million, up 25% over Q1 2025

Join the webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=JUSBp9Pa

Press Release: https://investors.biolifesolutions.com/2026-05-07-BioLife-Solutions-Reports-First-Quarter-2026-Financial-Results

05/05/2026

Get ready for the next G-Rex Grant Tour Stop in Boston, MA on Monday, May 11! 🦞☕

If you are attending the American Society of Gene & Cell Therapy Annual Meeting, come by the Artists for Humanity building after the show from 3:00-9:00pm.

Vicky Tran and Monica Wight Wight will be onsite at the BioLife table. We can’t wait to hear from the keynote patient-speaker and Sickle Cell Disease warrior, Victoria Gray, and from experts on the latest ex vivo CGT developments and manufacturing.

➡️ Register soon: https://www.scaleready.com/initiatives/g-rex-grant-tour-2026/g-rex-grant-tour-boston-ma

05/04/2026

As you build your itinerary for ISCT in Dublin this week, make sure to save this Bioprocess & Manufacturing Roundtable in the event app.

🎯 Topic: “Fresh vs. Frozen Apheresis: Scientific and Operational Implications for Cell Therapy Manufacturing”

🎤 Session Chair: Olga Bukatova, Associate Director of Business Development Cell & Gene Therapy, Azenta Life Sciences

🗣️ Panelists:
Dr. Alireza Abazari, Senior Director of Cell Processing and Cryopreservation, BioLife Solutions
Dr. Daniel Gonnermann, Assistant Director Cell Therapy Product Development, Haema Blut und Plasma (a Grifols Plasma partner)
Dr. Ralph Bradenberger, Master Principal; Head of CMC, Dark Horse Consulting Group, Inc.

📍 When/Where:
Wednesday, May 6
1:00-2:00pm IST (13:00)
Room: Wicklow Hall 2A

https://www.isctglobal.org/annual-meeting/program/programschedule

We hope to see you there for a lively discussion! 🍀

05/01/2026

As you build your itinerary for ISCT in Dublin next week, make sure to save this Bioprocess & Manufacturing Roundtable in the event app.

🎯 Topic: “Fresh vs. Frozen Apheresis: Scientific and Operational Implications for Cell Therapy Manufacturing”

🎤 Session Chair: Olga Bukatova, Associate Director of Business Development Cell & Gene Therapy, Azenta Life Sciences

🗣️ Panelists:
Dr. Alireza Abazari, Senior Director of Cell Processing and Cryopreservation, BioLife Solutions
Dr. Daniel Gonnermann, Assistant Director Cell Therapy Product Development, Haema Blut und Plasma (a Grifols Plasma partner)
Dr. Ralph Bradenberger, Master Principal; Head of CMC, Dark Horse Consulting Group, Inc.

📍 When/Where:
Wednesday, May 6
1:00-2:00pm IST (13:00)
Room: Wicklow Hall 2A

https://www.isctglobal.org/annual-meeting/program/programschedule

We hope to see you there for a lively discussion! 🍀